These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32973971)

  • 41. Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma.
    Villani A; Fabbrocini G; Costa C; Scalvenzi M
    Dermatol Ther (Heidelb); 2020 Jun; 10(3):401-412. PubMed ID: 32297221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
    Chang AL; Solomon JA; Hainsworth JD; Goldberg L; McKenna E; Day BM; Chen DM; Weiss GJ
    J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerging trends in the treatment of advanced basal cell carcinoma.
    Migden MR; Chang ALS; Dirix L; Stratigos AJ; Lear JT
    Cancer Treat Rev; 2018 Mar; 64():1-10. PubMed ID: 29407368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma.
    Chang AL; Lewis KD; Arron ST; Migden MR; Solomon JA; Yoo S; Day BM; McKenna EF; Sekulic A
    Oncotarget; 2016 Nov; 7(46):76118-76124. PubMed ID: 27764798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Actin in Muscle Spasms in a Case Series of Patients with Advanced Basal Cell Carcinoma Treated with a Hedgehog Pathway Inhibitor.
    Teh N; Leow LJ
    Dermatol Ther (Heidelb); 2021 Feb; 11(1):293-299. PubMed ID: 33200373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vismodegib: A Review in Advanced Basal Cell Carcinoma.
    Frampton JE; Basset-Séguin N
    Drugs; 2018 Jul; 78(11):1145-1156. PubMed ID: 30030732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness.
    Silapunt S; Chen L; Migden MR
    Ther Adv Med Oncol; 2016 Sep; 8(5):375-82. PubMed ID: 27583029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy.
    Ross AE; Hughes RM; Glavaris S; Ghabili K; He P; Anders NM; Harb R; Tosoian JJ; Marchionni L; Schaeffer EM; Partin AW; Allaf ME; Bivalacqua TJ; Chapman C; O'Neal T; DeMarzo AM; Hurley PJ; Rudek MA; Antonarakis ES
    Oncotarget; 2017 Nov; 8(61):104182-104192. PubMed ID: 29262631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting the Hedgehog Pathway for Locally Advanced and Metastatic Basal Cell Carcinoma.
    Yin VT; Esmaeli B
    Curr Pharm Des; 2017; 23(4):655-659. PubMed ID: 27928965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exposure-QT analysis for sonidegib (LDE225), an oral inhibitor of the hedgehog signaling pathway, for measures of the QT prolongation potential in healthy subjects and in patients with advanced solid tumors.
    Quinlan M; Zhou J; Hurh E; Sellami D
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1427-1432. PubMed ID: 27663457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vismodegib-resistant basal cell carcinomas in basal cell nevus syndrome: Clinical approach and genetic analysis.
    Sinx KAE; Roemen GMJM; van Zutven V; Janssen R; Speel EM; Steijlen PM; van Geel M; Mosterd K
    JAAD Case Rep; 2018 Jun; 4(5):408-411. PubMed ID: 29984265
    [No Abstract]   [Full Text] [Related]  

  • 52. Sonidegib for the treatment of advanced basal cell carcinoma.
    Ramelyte E; Amann VC; Dummer R
    Expert Opin Pharmacother; 2016 Oct; 17(14):1963-8. PubMed ID: 27538055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors.
    Stathis A; Hess D; von Moos R; Homicsko K; Griguolo G; Joerger M; Mark M; Ackermann CJ; Allegrini S; Catapano CV; Xyrafas A; Enoiu M; Berardi S; Gargiulo P; Sessa C;
    Invest New Drugs; 2017 Dec; 35(6):766-772. PubMed ID: 28317088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. First reported case of concurrent sonidegib and radiotherapy for recurrent, advanced basal cell carcinoma.
    Wang K; Patel M; Prabhu AV; Lewis GD
    Rep Pract Oncol Radiother; 2021; 26(1):149-152. PubMed ID: 34046226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma.
    Odom D; Mladsi D; Purser M; Kaye JA; Palaka E; Charter A; Jensen JA; Sellami D
    J Skin Cancer; 2017; 2017():6121760. PubMed ID: 28607774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas.
    Wahid M; Jawed A; Mandal RK; Dar SA; Khan S; Akhter N; Haque S
    Crit Rev Oncol Hematol; 2016 Feb; 98():235-41. PubMed ID: 26614022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort study.
    Goldenberg G; Karagiannis T; Palmer JB; Lotya J; O'Neill C; Kisa R; Herrera V; Siegel DM
    J Am Acad Dermatol; 2016 Nov; 75(5):957-966.e2. PubMed ID: 27473450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral Hedgehog Pathway Inhibition as a Means for Ocular Salvage in Locally Advanced Intraorbital Basal Cell Carcinoma.
    Mathis J; Doerr T; Lin E; Ibrahim SF
    Dermatol Surg; 2019 Jan; 45(1):17-25. PubMed ID: 30586344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comprehensive review of the role of the hedgehog pathway and vismodegib in the management of basal cell carcinoma.
    Erdem GU; Sendur MA; Ozdemir NY; Yazıcı O; Zengin N
    Curr Med Res Opin; 2015 Apr; 31(4):743-56. PubMed ID: 25690490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors.
    Weiss GJ; Korn RL
    Cancer; 2012 Nov; 118(21):5310-9. PubMed ID: 22511370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.